Unknown

Dataset Information

0

Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.


ABSTRACT: The emergence of the pandemic 2009 H1N1 influenza virus has become a world-wide health concern. As drug resistance appears, a new generation of therapeutic strategies will be required. Here, we introduce a nanotechnology approach for the therapy of pan-demic and seasonal influenza virus infections. This approach uses gold nanorods (GNRs) to deliver an innate immune activator, pro-ducing a localized therapeutic response. We demonstrated the utility of a biocompatible gold nanorod, GNR-5'PPP-ssRNA nanoplex, as an antiviral strategy against type A influenza virus. In human respiratory bronchial epithelial cells, this nanoplex activated the retinoic acid-inducible gene I (RIG-I) pathogen recognition pathway, resulting in increased expression of IFN-beta and other IFN-stimulated genes (ISGs) (e.g., PKR, MDA5, IRF1, IRF7, and MX1). This increase in type I IFN and ISGs resulted in a decrease in the replication of H1N1 influenza viruses. These findings suggest that further evaluation of biocompatible nanoplexes as unique antivirals for treatment of seasonal and pandemic influenza viruses is warranted.

SUBMITTER: Chakravarthy KV 

PROVIDER: S-EPMC2890428 | biostudies-other | 2010 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.

Chakravarthy Krishnan V KV   Bonoiu Adela C AC   Davis William G WG   Ranjan Priya P   Ding Hong H   Hu Rui R   Bowzard J Bradford JB   Bergey Earl J EJ   Katz Jacqueline M JM   Knight Paul R PR   Sambhara Suryaprakash S   Prasad Paras N PN  

Proceedings of the National Academy of Sciences of the United States of America 20100524 22


The emergence of the pandemic 2009 H1N1 influenza virus has become a world-wide health concern. As drug resistance appears, a new generation of therapeutic strategies will be required. Here, we introduce a nanotechnology approach for the therapy of pan-demic and seasonal influenza virus infections. This approach uses gold nanorods (GNRs) to deliver an innate immune activator, pro-ducing a localized therapeutic response. We demonstrated the utility of a biocompatible gold nanorod, GNR-5'PPP-ssRNA  ...[more]

Similar Datasets

| S-EPMC3256529 | biostudies-other
| S-EPMC3034774 | biostudies-other
| S-EPMC3488283 | biostudies-literature
| S-EPMC8692537 | biostudies-literature
| S-EPMC2948498 | biostudies-other
| S-EPMC4891568 | biostudies-literature
| S-EPMC3204747 | biostudies-literature
| S-EPMC3769975 | biostudies-literature
| S-EPMC3727314 | biostudies-literature
| S-EPMC3215438 | biostudies-other